EUVIMEDEUVIMED entdecken
Open Access

Patient Preferences for Pain Control After Mohs Micrographic Surgery

Shannon T Nugent, Surya A Veerabagu, Matthew Madden, Arianna F Yanes, Jeremy R Etzkorn, Christopher J Miller, Joseph F Sobanko, Thuzar M Shin, H William Higgins, Stacy L McMurray, Joanna L Walker, Junqian Zhang und 1 weitere

JAMA Dermatology · 01.08.2023 · 159 (8) · 848

DOI: 10.1001/jamadermatol.2023.1899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.08.2023. Verfasst von Shannon T Nugent und 12 weiteren Autor:innen. Beteiligte Einrichtung: Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Pain Management, Opioid-Related Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Patient preferences for pain medications after Mohs micrographic surgery are important to understand and have not been fully studied.

Objective

To evaluate patient preferences for pain management with only over-the-counter medications (OTCs) or OTCs plus opioids after Mohs micrographic surgery given varying levels of theoretical pain and opioid addiction risk. Design, Setting, and Participants This prospective discrete choice experiment was conducted in a single academic medical center from August 2021 to April 2022 among patients undergoing Mohs surgery and their accompanying support persons (≥18 years). A prospective survey was administered to all participants using the Conjointly platform. Data were analyzed from May 2022 to February 2023. Main outcome and measure The primary outcome was the pain level at which half of the respondents chose OTCs plus opioids equally to only OTCs for pain management. This pain threshold was determined for varying opioid addiction risk profiles (low, 0%; low-moderate, 2%; moderate-high, 6%; high, 12%) and measured via a discrete choice experiment and linear interpolation of associated parameters (pain levels and risk of addiction).

Results

Of the 295 respondents (mean [SD] age, 64.6 [13.1] years; 174 [59%] were female; race and ethnicity were not considered) who completed the discrete choice experiment, 101 (34%) stated that they would never consider opioids for pain management regardless of the pain level experienced, and 147 (50%) expressed concern regarding possible opioid addiction. Across all scenarios, 224 respondents (76%) preferred only OTCs vs OTCs plus opioids after Mohs surgery for pain control. When the theoretical risk of addiction was low (0%), half of the respondents expressed a preference for OTCs plus opioids given pain levels of 6.5 on a 10-point scale (90% CI, 5.7-7.5). At higher opioid addiction risk profiles (2%, 6%, 12%), an equal preference for OTCs plus opioids and only OTCs was not achieved. In these scenarios, patients favored only OTCs despite experiencing high levels of pain. Conclusion and relevance The findings of this prospective discrete choice experiment indicate that the perceived risk of opioid addiction affects the patient’s choice of pain medications after Mohs surgery. It is important to engage patients undergoing Mohs surgery in shared decision-making discussions to determine the optimal pain control plan for each individual. These findings may encourage future research on the risks associated with long-term opioid use after Mohs surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pain ManagementOpioid-Related DisordersHumansFemaleMiddle AgedMaleAnalgesics, OpioidMohs SurgeryPatient PreferenceProspective StudiesPain

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Department of Dermatology, University of New Mexico, Albuquerque.
  • Brigham Young University, Provo, Utah.
  • Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia.

Zitieren

APA

Nugent, S. T., Veerabagu, S. A., Madden, M., Yanes, A. F., Etzkorn, J. R., Miller, C. J., Sobanko, J. F., Shin, T. M., Higgins, H. W., McMurray, S. L., Walker, J. L., Zhang, J., & Giordano, C. N. (2023). Patient Preferences for Pain Control After Mohs Micrographic Surgery. JAMA Dermatology, 159(8), 848. https://doi.org/10.1001/jamadermatol.2023.1899

Vancouver

Nugent ST, Veerabagu SA, Madden M, Yanes AF, Etzkorn JR, Miller CJ, et al. Patient Preferences for Pain Control After Mohs Micrographic Surgery. JAMA Dermatology. 2023;159(8):848. doi:10.1001/jamadermatol.2023.1899

BibTeX
@article{Nugent2023,
  author = {Nugent, Shannon T and Veerabagu, Surya A and Madden, Matthew and Yanes, Arianna F and Etzkorn, Jeremy R and Miller, Christopher J and Sobanko, Joseph F and Shin, Thuzar M and Higgins, H William and McMurray, Stacy L and Walker, Joanna L and Zhang, Junqian and Giordano, Cerrene N},
  title = {Patient Preferences for Pain Control After Mohs Micrographic Surgery},
  journal = {JAMA Dermatology},
  year = {2023},
  volume = {159},
  number = {8},
  pages = {848},
  doi = {10.1001/jamadermatol.2023.1899}
}
Kostenlos starten →